Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Medicine
    • Ciprofloxacin No...

    Ciprofloxacin No longer Effective In Shigellosis, Typhoid

    Written by supriya kashyap kashyap Published On 2017-04-25T15:31:36+05:30  |  Updated On 25 April 2017 3:31 PM IST
    Ciprofloxacin No longer Effective In Shigellosis, Typhoid

    Hyderabad : Researchers have found that indiscriminate and irresponsible use of ciprofloxacin which used to be sufficiently capable to kill Shigella bacteria that causes severe diarrhoea and even deaths in children is no longer effective against them. It is reported that new strains of Shigella have developed resistance to the powerful antibiotic. Shigella, along with bacteria like rotavirus, E coli, Salmonella and Campylobacter, causes severe diarrhoea and dysentery in the country. They are transmitted mostly by contaminated water and food.


    The random and reckless use of antibiotics has led to a fast-approaching crisis in the form of Antibiotic Resistance. Center for Disease Control and Prevention (CDC) of USA has already issued a warning against emerging strains of Shigella bacteria with reduced susceptibility to ciprofloxacin. "Strains of Shigella developing resistance to ciprofloxacin ,main antibiotic drug used for treatment of shigellosis is a big blow to the healthcare system.


    On one hand, physicians will be left with no choice other than administering stronger antibiotics and on other hand this will lead to increased healthcare costs.It is reported that there is increased incidence of resistance to Ciprofloxacin in shigellosis in Telangana and AP this will result in increased morbidity and high mortality and loss of manpower hours.


    Unfortunately, Ciprofloxacin has also become ineffective against resistant strains Salmonella typhi which is cause of Typhoid according to another Media Report. A research published in Journal of Global Infectious Di urnal of Global Infectious Diseases in 2010 by Safdarjung doctors had pre-empted the problem. Ciprofloxacin, they wrote, has become a norm for treating enteric fever or typhoid, but in future novel molecular substitutions (new antibiotics) may become frequent owing to irrational use of ciprofloxacin in human and veterinary therapeutics, in a population endemic with nalidixic acid-resistant strains. At present treatment of ciprofloxacin-resistant enteric fever has narrowed down to third and fourth generation cephalosporins, azithromycin, tigecycline and penems.


    In addition to the Problem of Antibiotic Resistance, the Pharma industry is not motivated to renew research efforts for developing newer antibiotic due to lack of Economic Incentives which is a cause of concern.

    CampylobacterCiprofloxacinDiarrhoeaJournal of Global Infectious DiShigella bacteriaShigellosisTyphoid

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok